Donor chooses ACGT for brain cancer research to honor late husband

May 01, 2024
Devin Golden

The Lowe Family — Blake, Lori, Ming and Claudia (left to right).

Lori Lowe met the love of her life nearly 30 years ago while attending Purdue University. Her college sweetheart, Ming, believed in finding joy and beauty in everyday life. Rooted in his faith, he lived purposefully, following his passions with vigor and openness rather than filling bucket lists.

It has been two years since her husband Ming, a vibrant adventurer with a heart of gold, succumbed to glioblastoma multiforme, the relentless and aggressive form of brain cancer.

This led Lori to learn about Alliance for Cancer Gene Therapy (ACGT), the first and only nonprofit organization committed to supporting the underfunded-yet-promising science of cancer cell and gene therapy.

Ming Lowe ‘made the most of every moment.’

Ming was a professional pilot with boundless enthusiasm for life. He had a passion for travel and helping others, and his warm smile and compassionate nature touched the lives of countless people.

He took his role as a husband and father even more seriously and loved time with family. After his diagnosis, he demonstrated unwavering courage, faith and positivity, determined to make the most of every moment.

“Ming was a fitness enthusiast who led a very healthy lifestyle prior to his sudden illness. He was in the prime of his career and family life. He was charismatic and loved to make others laugh,” Lori said. “He underwent three years of aggressive treatments, including three brain surgeries, with the cancer returning each time more aggressively.”

Lori invests in finding a cure for glioblastoma.

After Ming’s passing, Lori wanted to ensure that her late husband‘s legacy lived on. She knew that glioblastoma is a formidable disease, and she wanted to contribute to finding a cure. To honor Ming’s spirit and his love for helping others, Lori decided she would donate to a non-profit organization that aligned with her beliefs.

After thorough research, her family chose to support ACGT, making their first donation in 2023. She firmly believes that research is the key to providing cancer patients with more treatment options and, ultimately, hope for a better future.

“Unlike many other forms of cancer, glioblastoma patients have not had a significant advancement in many decades. Greater innovation is desperately needed to make medical advancements that give patients more time with loved ones,” Lori said. “We have met many other families affected by glioblastoma. It is not as rare as people think, killing more than 10,000 Americans a year. We are funding hope for the brain tumor community.”

By donating to ACGT, Lori and her family aimed to contribute to the legacy Ming had left behind – a legacy of love, adventure and a desire to make the world a better place. The research and advancements made possible by her donation may pave the way for a brighter future for cancer patients and their families.

For more information on donating to ACGT, please contact Keri Eisenberg at (203) 358-5055 or email